• LAST PRICE
    8.0100
  • TODAY'S CHANGE (%)
    Trending Down-0.4800 (-5.6537%)
  • Bid / Lots
    8.0100/ 5
  • Ask / Lots
    8.0200/ 56
  • Open / Previous Close
    8.5000 / 8.4900
  • Day Range
    Low 7.9501
    High 8.5237
  • 52 Week Range
    Low 7.1300
    High 20.2400
  • Volume
    1,917,260
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 8.49
TimeVolumeAVXL
09:32 ET394108.3672
09:33 ET189148.34
09:35 ET265998.295
09:37 ET114588.295
09:39 ET476298.219
09:42 ET71538.2964
09:44 ET181768.28
09:46 ET180178.21
09:48 ET106018.2752
09:50 ET288858.25
09:51 ET42258.33
09:53 ET33428.345
09:55 ET130008.28
09:57 ET43018.3198
10:00 ET121048.33
10:02 ET90538.29
10:04 ET134878.25
10:06 ET76618.32
10:08 ET80748.34
10:09 ET85228.33
10:11 ET269588.43
10:13 ET74118.405
10:15 ET368528.46
10:18 ET173198.52
10:20 ET89268.45
10:22 ET191078.37
10:24 ET44008.3586
10:26 ET184168.275
10:27 ET56138.285
10:29 ET6008.3
10:31 ET111548.235
10:33 ET95268.23
10:36 ET423288.195
10:38 ET231778.23
10:40 ET364848.12
10:42 ET232898.08
10:44 ET200718.07
10:45 ET290968.1
10:47 ET231568.0676
10:49 ET764267.97
10:51 ET306077.98
10:54 ET315758.03
10:56 ET109878.0683
10:58 ET105728.0799
11:00 ET33278.09
11:02 ET243118.12
11:03 ET60238.145
11:05 ET176178.1592
11:07 ET107328.09
11:09 ET200908.02
11:12 ET45958.0893
11:14 ET63078.0893
11:16 ET105058.08
11:18 ET97938.08
11:20 ET282888.07
11:21 ET367148.115
11:23 ET309278.13
11:25 ET48158.13
11:27 ET29958.15
11:30 ET53638.199
11:32 ET57558.16
11:36 ET59858.185
11:38 ET70928.22
11:39 ET62228.24
11:41 ET81708.24
11:43 ET49508.21
11:45 ET41258.17
11:48 ET39738.16
11:50 ET32228.16
11:52 ET43288.165
11:54 ET5008.18
11:56 ET73438.15
11:57 ET54718.13
11:59 ET161308.1
12:01 ET286578.0619
12:03 ET72528.095
12:06 ET55328.07
12:08 ET20418.11
12:10 ET35838.155
12:12 ET243518.205
12:14 ET61508.185
12:15 ET46688.12
12:17 ET87298.1299
12:19 ET12998.11
12:21 ET22468.07
12:24 ET24508.07
12:26 ET141948.05
12:28 ET18308.07
12:30 ET34808.05
12:32 ET54888.0623
12:33 ET21028.04
12:35 ET63028.06
12:37 ET14008.0871
12:39 ET68448.1185
12:42 ET58658.14
12:44 ET52978.16
12:46 ET76278.115
12:48 ET12148.1
12:50 ET70578.14
12:51 ET72578.1573
12:53 ET25588.182
12:55 ET107248.19
12:57 ET26118.19
01:00 ET33788.17
01:02 ET43008.19
01:04 ET61888.18
01:06 ET3008.1701
01:08 ET55178.1859
01:09 ET41608.18
01:11 ET13008.17
01:13 ET65658.14
01:15 ET39688.17
01:18 ET14008.17
01:20 ET107498.165
01:22 ET66108.16
01:24 ET108928.18
01:26 ET41008.185
01:27 ET141208.19
01:29 ET83908.19
01:31 ET78008.1919
01:33 ET129558.19
01:36 ET49808.1906
01:38 ET41198.2
01:40 ET107098.2001
01:42 ET125548.22
01:44 ET71178.2116
01:45 ET46278.22
01:47 ET25008.202
01:49 ET61368.22
01:51 ET104908.18
01:54 ET14508.1659
01:56 ET34358.14
01:58 ET129658.13
02:00 ET13328.13
02:02 ET24988.11
02:03 ET183808.109
02:05 ET167018.0772
02:07 ET79518.05
02:09 ET36808.095
02:12 ET17508.07
02:14 ET70588.0626
02:16 ET31118.06
02:18 ET80978.07
02:20 ET137898.054
02:21 ET39808.07
02:23 ET24208.07
02:25 ET77808.065
02:27 ET62228.05
02:30 ET95218.03
02:32 ET126068.02
02:34 ET58268.01
02:36 ET177158.01
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAVXL
Anavex Life Sciences Corp
661.9M
-12.9x
---
United StatesMRSN
Mersana Therapeutics Inc
668.5M
-2.7x
---
United StatesALVR
Allovir Inc
651.2M
-2.6x
---
United StatesALLK
Allakos Inc
645.8M
-1.1x
---
United StatesBLUE
bluebird bio Inc
658.3M
-1.4x
---
United StatesSPRY
ARS Pharmaceuticals Inc
700.4M
-3.1x
---
As of 2022-12-08

Company Information

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders. The Company’s lead compound ANAVEX2-73 is being developed to treat Alzheimer’s disease, Parkinson’s disease, and other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by mutations in the X-linked gene, methyl-CpG-binding protein 2 (MECP2). Its product candidates also include ANAVEX 3-71, ANAVEX 1-41, ANAVEX 1066, and ANAVEX 1037. ANAVEX 3-71 is a central nervous system (CNS) penetrable potential disease modifying treatment for cognitive impairments. ANAVEX 1-41 is a sigma-1 agonist. ANAVEX 1066, a mixed sigma-1/sigma-2 ligand, is designed for the potential treatment of neuropathic and visceral pain. ANAVEX 1037 is designed for the treatment of prostate and pancreatic cancer.

Contact Information

Headquarters
7TH FLOOR, 51 W 52ND STREET,NEW YORK, NY, United States 10019-6163
Phone
800-689-3939
Fax
---

Executives

Chairman of the Board, President, Chief Executive Officer, Company Secretary
Christopher Missling
Principal Financial Officer, Treasurer
Sandra Boenisch
Lead Independent Director
Claus van der Velden
Independent Director
Peter Donhauser
Independent Director
Jiong Ma

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$661.9M
Revenue (TTM)
$0.00
Shares Outstanding
78.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.72
EPS
$-0.62
Book Value
$1.83
P/E Ratio
-12.9x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.